(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
The U.S. Supreme Court on Thursday unanimously threw out attempts to patent human genes, siding with advocates who say the multibillion-dollar biotechnology industry should not have exclusive control over ...
The Supreme Court seemed worried Monday about the idea of companies patenting human genes in a case that could profoundly reshape the multibillion-dollar biomedical industry and U.S. research in the fight ...
The Supreme Court will examine the North Carolina dental regulatory board's claim that only dentists should be allowed to whiten teeth.
A Florida inmate is challenging the US state's use of a rigid IQ number to determine intellectual disability, in a case that spotlights the issue of the mentally ill on death row.
A US court has dealt a new blow to the health care reform law seen as President Barack Obama's proudest domestic achievement, declaring its centerpiece provision unconstitutional.
One quarter of Americans report problems paying for medical bills, and more than half say they have skipped or cut back on health care due to the cost, according to a survey released Monday.
More than four decades after legalizing abortion, the US Supreme Court returns to the hot-button issue Wednesday in a case about the right to protest near clinics that terminate pregnancies.
The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
The US Supreme Court will hear arguments Monday on whether to allow private entities to patent genes they have isolated and identified, a decision that could have far-reaching implications for genetic research.
Can human genes be patented? That was the question posed by Alan J. Snyder, vice president and associate provost for research and graduate studies at Lehigh, and Lee Kaplan, scientific director of cellular and molecular genetics ...
The US Supreme Court declined Monday to enter the emotionally-charged debate over stem cell research, refusing to hear an appeal centered on the issue of federal government funding.
The Food and Drug Administration is seeking a rule change to allow generic drugmakers to quickly update their warning labels with new safety information for doctors and patients.
The U.S. Supreme Court seemed likely Wednesday to strike down a state of Massachusetts law setting a 35-foot (10 meter) protest-free zone outside abortion clinics.
(AP)—The Supreme Court is struggling with whether it should stop pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.